Get the Stockscreener App
26.89
6.86%
-1.98
Crinetics Pharmaceuticals Inc Stock (CRNX) Forecast
The Crinetics Pharmaceuticals Inc (CRNX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $36.37, representing a +35.24% increase from the current price of $26.89. The highest analyst price target is $38.31, and the lowest is $34.42.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRNX Price Target
Average 40.25
(+49.69% Upside)
Is Crinetics Pharmaceuticals Inc (CRNX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.75 | Buy |
| STOCH(9,6) | 25.04 | Neutral |
| STOCHRSI(14) | 20.65 | Neutral |
| MACD(12,26) | -1.6298 | Sell |
| ADX(14) | 24.32 | Neutral |
| William %R | -95.89 | Buy |
| CCI(14) | -259.20 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
32.65
Sell
|
31.54
Sell
|
| MA20 |
33.61
Sell
|
32.96
Sell
|
| MA50 |
35.26
Sell
|
36.19
Sell
|
| MA100 |
43.72
Sell
|
40.71
Sell
|
| MA200 |
47.98
Sell
|
43.50
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CRNX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CRNX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.75 indicates that CRNX is oversold. This indicates that CRNX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 25.04 indicates that CRNX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.65 indicates that CRNX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.32 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -259.2 indicates that CRNX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CRNX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Crinetics Pharmaceuticals Inc financial reports and earnings history, Crinetics Pharmaceuticals Inc (CRNX) stock could reach $67.40 by 2030, $111.71 by 2040 and $156.89 by 2050. See the projected annual prices until 2050 of the Crinetics Pharmaceuticals Inc stock below:
- Crinetics Pharmaceuticals Inc (CRNX) is expected to reach an average price of $96.48 in 2035, with a high prediction of $97.36 and a low estimate of $90.04. This indicates an $258.80% rise from the last recorded price of $26.89.
- Crinetics Pharmaceuticals Inc (CRNX) stock is projected to chart a bullish course in 2040, with an average price target of $111.29, representing an $313.88% surge from its current level. The forecast ranges from a conservative $106.92 to a sky-high $111.71.
- Our analysts predict Crinetics Pharmaceuticals Inc (CRNX) to jump 395.68% by 2045, soaring from $133.22 to an average price of $133.29, potentially reaching $137.02. While $133.22 is the low estimate, the potential upside is significant.
- Crinetics Pharmaceuticals Inc (CRNX) stock is expected to climb by 2050, reaching an average of $156.64, a $482.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $156.89 and $154.13, respectively, highlighting the market's uncertainty.
Crinetics Pharmaceuticals Inc Stock (CRNX) Year by Year Forecast
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2025
Crinetics Pharmaceuticals Inc Stock (CRNX) is expected to reach an average price of $40.05 in 2025, with a high prediction of $47.83 and a low estimate of $32.27. This indicates an +48.94% rise from the last recorded price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $37.87 | $34.42 | $38.31 | +40.82% |
| June, 2025 | $41.83 | $37.46 | $42.23 | +55.57% |
| July, 2025 | $45.62 | $37.29 | $46.08 | +69.64% |
| August, 2025 | $37.86 | $37.67 | $45.23 | +40.80% |
| September, 2025 | $38.91 | $35.84 | $39.57 | +44.69% |
| October, 2025 | $37.06 | $36.46 | $39.97 | +37.83% |
| November, 2025 | $38.88 | $36.62 | $39.91 | +44.58% |
| December, 2025 | $35.53 | $35.15 | $41.19 | +32.14% |
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2026
The predicted value for Crinetics Pharmaceuticals Inc (CRNX) in 2026 is set at an average of $43.23. Estimates vary from a peak of $51.35 to a trough of $35.11, indicating an +60.76% surge from the present price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $38.01 | $35.11 | $38.26 | +41.34% |
| February, 2026 | $37.01 | $36.34 | $38.04 | +37.64% |
| March, 2026 | $38.25 | $36.71 | $39.34 | +42.24% |
| April, 2026 | $40.79 | $38.01 | $42.32 | +51.70% |
| May, 2026 | $40.97 | $38.22 | $42.12 | +52.35% |
| June, 2026 | $41.74 | $39.42 | $43.91 | +55.24% |
| July, 2026 | $41.14 | $39.87 | $42.88 | +52.98% |
| August, 2026 | $42.09 | $40.99 | $43.46 | +56.54% |
| September, 2026 | $46.35 | $42.21 | $46.80 | +72.36% |
| October, 2026 | $43.05 | $42.58 | $46.54 | +60.10% |
| November, 2026 | $49.32 | $42.28 | $49.76 | +83.40% |
| December, 2026 | $47.03 | $46.21 | $51.35 | +74.90% |
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Crinetics Pharmaceuticals Inc (CRNX) is $49.59, with a high forecast of $55.72 and a low forecast of $43.45. This indicates an +84.41% increase from the last price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $48.68 | $45.16 | $49.82 | +81.02% |
| February, 2027 | $53.64 | $47.39 | $55.11 | +99.49% |
| March, 2027 | $51.13 | $49.31 | $54.40 | +90.13% |
| April, 2027 | $50.83 | $49.74 | $55.72 | +89.04% |
| May, 2027 | $44.52 | $43.45 | $50.21 | +65.55% |
| June, 2027 | $45.60 | $44.24 | $47.56 | +69.59% |
| July, 2027 | $49.41 | $44.89 | $49.95 | +83.74% |
| August, 2027 | $48.67 | $48.52 | $55.46 | +81.01% |
| September, 2027 | $44.69 | $43.92 | $49.99 | +66.18% |
| October, 2027 | $46.38 | $44.00 | $49.56 | +72.49% |
| November, 2027 | $49.41 | $45.48 | $50.48 | +83.74% |
| December, 2027 | $49.08 | $46.33 | $51.20 | +82.53% |
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2028
In 2028, Crinetics Pharmaceuticals Inc (CRNX) is projected to reach an average price of $50.12, with a high projection of $55.26 and a low estimate of $44.98. This indicates an +86.39% rise from the last price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $48.95 | $46.87 | $51.43 | +82.03% |
| February, 2028 | $48.56 | $46.71 | $51.02 | +80.60% |
| March, 2028 | $47.63 | $45.47 | $48.70 | +77.12% |
| April, 2028 | $47.45 | $46.03 | $49.23 | +76.47% |
| May, 2028 | $46.31 | $44.98 | $48.10 | +72.21% |
| June, 2028 | $49.60 | $45.62 | $49.67 | +84.46% |
| July, 2028 | $49.60 | $48.70 | $51.50 | +84.45% |
| August, 2028 | $47.52 | $47.26 | $51.05 | +76.73% |
| September, 2028 | $46.33 | $45.59 | $48.65 | +72.28% |
| October, 2028 | $52.98 | $45.99 | $54.88 | +97.04% |
| November, 2028 | $52.89 | $52.12 | $55.26 | +96.68% |
| December, 2028 | $49.09 | $48.76 | $53.42 | +82.57% |
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2029
The 2029 price forecast for Crinetics Pharmaceuticals Inc Stock (CRNX) is $65.11 on average, with a high prediction of $82.90 and a low estimate of $47.32. This represents an +142.13% increase from the previous price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $50.32 | $48.75 | $52.23 | +87.12% |
| February, 2029 | $48.59 | $47.32 | $50.84 | +80.71% |
| March, 2029 | $61.20 | $47.42 | $62.71 | +127.59% |
| April, 2029 | $61.01 | $57.20 | $62.33 | +126.90% |
| May, 2029 | $59.08 | $57.90 | $63.51 | +119.70% |
| June, 2029 | $65.08 | $58.11 | $65.54 | +142.03% |
| July, 2029 | $68.12 | $64.61 | $70.37 | +153.32% |
| August, 2029 | $69.26 | $66.26 | $71.62 | +157.58% |
| September, 2029 | $69.83 | $68.53 | $73.43 | +159.68% |
| October, 2029 | $77.51 | $69.61 | $80.70 | +188.26% |
| November, 2029 | $76.39 | $75.60 | $82.90 | +184.07% |
| December, 2029 | $64.30 | $63.32 | $79.55 | +139.12% |
Crinetics Pharmaceuticals Inc Stock (CRNX) Price Forecast for 2030
Crinetics Pharmaceuticals Inc Stock (CRNX) is expected to reach an average price of $61.45 in 2030, with a high forecast of $68.98 and a low forecast of $53.92. This signifies an +128.52% surge from the last price of $26.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $60.52 | $60.27 | $67.40 | +125.08% |
| February, 2030 | $63.65 | $60.39 | $65.55 | +136.70% |
| March, 2030 | $58.54 | $58.15 | $64.90 | +117.70% |
| April, 2030 | $55.87 | $55.74 | $59.57 | +107.78% |
| May, 2030 | $55.73 | $54.94 | $59.42 | +107.25% |
| June, 2030 | $58.25 | $55.74 | $59.06 | +116.62% |
| July, 2030 | $60.28 | $57.74 | $62.38 | +124.17% |
| August, 2030 | $63.62 | $60.11 | $64.72 | +136.61% |
| September, 2030 | $67.83 | $64.24 | $68.98 | +152.25% |
| October, 2030 | $65.17 | $63.76 | $68.53 | +142.35% |
| November, 2030 | $56.42 | $55.58 | $67.32 | +109.82% |
| December, 2030 | $56.38 | $53.92 | $59.88 | +109.67% |
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):